日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/01/21 | 日証協 | 121,459株 | -48.48% | 68,220株 | +136.58% | 557,133株 | -4.37% | 53,812株 | +9.82% |
2022/01/14 | 日証協 | 235,745株 | -12.25% | 28,836株 | -83.63% | 582,621株 | +8.25% | 49,000株 | -71.33% |
2022/01/07 | 日証協 | 268,645株 | +15.6% | 176,167株 | +425.89% | 538,221株 | +51.3% | 170,900株 | +326.68% |
2021/12/30 | 日証協 | 232,400株 | 0% | 33,499株 | 0% | 355,721株 | 0% | 40,053株 | 0% |
2021/12/24 | 日証協 | 232,400株 | -9.93% | 33,499株 | -61.48% | 355,721株 | -8.32% | 40,053株 | +83.73% |
2021/12/17 | 日証協 | 258,017株 | +26.83% | 86,975株 | -50.04% | 388,018株 | -3.55% | 21,800株 | -78.2% |
2021/12/10 | 日証協 | 203,442株 | +149.06% | 174,096株 | +314.61% | 402,319株 | +22.28% | 100,002株 | +155.76% |
2021/12/03 | 日証協 | 81,683株 | -3.23% | 41,990株 | -48.87% | 329,022株 | +1.61% | 39,100株 | -17.16% |
2021/11/26 | 日証協 | 84,413株 | +59.08% | 82,120株 | +150.06% | 323,822株 | +2.66% | 47,200株 | +24.15% |
2021/11/19 | 日証協 | 53,062株 | +16.26% | 32,840株 | +6.55% | 315,422株 | +6.95% | 38,018株 | -33.08% |
2021/11/05 | 日証協 | 55,700株 | +28.58% | 21,100株 | -39.66% | 319,554株 | +6.98% | 35,118株 | -56.8% |
2021/10/29 | 日証協 | 43,320株 | +33.38% | 34,969株 | -2.53% | 298,695株 | -0.08% | 81,299株 | +206.22% |
2021/10/22 | 日証協 | 32,478株 | -20.74% | 35,878株 | +3.75% | 298,923株 | -4.6% | 26,549株 | +7.05% |
2021/10/15 | 日証協 | 40,979株 | +11.36% | 34,580株 | +7.06% | 313,333株 | -1.48% | 24,801株 | +117.55% |
2021/10/08 | 日証協 | 36,799株 | -54.96% | 32,300株 | -94.01% | 318,032株 | -57.35% | 11,400株 | -98.48% |
2021/10/01 | 日証協 | 81,699株 | -41.64% | 538,920株 | +94.61% | 745,632株 | -7.06% | 748,564株 | +93.32% |
2021/09/24 | 日証協 | 139,999株 | +21.34% | 276,920株 | +19.72% | 802,231株 | +13.5% | 387,210株 | +23.91% |
2021/09/17 | 日証協 | 115,379株 | +44.86% | 231,300株 | +252.05% | 706,821株 | +23.03% | 312,500株 | +57% |
2021/09/10 | 日証協 | 79,648株 | +195.56% | 65,700株 | +145.62% | 574,521株 | +55.62% | 199,050株 | +308.73% |
※株式分割は考慮していませんのでご注意ください。
Page Top